- |||||||||| Avastin (bevacizumab) / Roche, parsatuzumab (RG7414) / Roche
Trial completion, Trial primary completion date, Combination therapy, Metastases: A Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab and mFOLFOX-6 in Participants With Previously Untreated Metastatic Colorectal Cancer (clinicaltrials.gov) - Jul 2, 2015 P2, N=128, Completed, Active, not recruiting --> Completed | Trial primary completion date: Feb 2014 --> Oct 2014 Active, not recruiting --> Completed | Trial primary completion date: Jan 2015 --> Feb 2014
- |||||||||| dilpacimab (ABT-165) / AbbVie
Enrollment change, Metastases: A Study of ABT-165 in Subjects With Solid Tumors (clinicaltrials.gov) - Jul 1, 2015 P1, N=100, Recruiting, Active, not recruiting --> Completed | Trial primary completion date: Jan 2015 --> Feb 2014 N=75 --> 100
- |||||||||| leucovorin calcium / Generic mfg., cisplatin / Generic mfg., paclitaxel / Generic mfg.
Trial completion, Surgery: Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer (clinicaltrials.gov) - Jun 23, 2015 P2, N=39, Completed, Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2015 --> Oct 2015 Active, not recruiting --> Completed
- |||||||||| 5-fluorouracil / Generic mfg., metformin / Generic mfg., leucovorin calcium / Generic mfg.
Trial primary completion date, Metastases: Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer (clinicaltrials.gov) - Jun 11, 2015 P2, N=43, Recruiting, Trial primary completion date: Jun 2015 --> Dec 2016 Trial primary completion date: May 2015 --> Nov 2015
- |||||||||| 5-fluorouracil / Generic mfg., leucovorin calcium / Generic mfg.
Trial termination, Combination therapy, Metastases: PEPCOL: Liposome-encapsulated Irinotecan Hydrochloride PEP02 or Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil as Second-Line Therapy in Treating Patients With Metastatic Colorectal Cancer (clinicaltrials.gov) - Jun 11, 2015 P2, N=55, Terminated, Recruiting --> Terminated | Trial primary completion date: Dec 2014 --> Jun 2015; Recruitment almost complete, has been slow and challenging Suspended --> Terminated; efficacy interim analysis as per protocol
- |||||||||| Neupogen (filgrastim) / Kyowa Kirin, Amgen, NN1213 / Novo Nordisk
Trial termination, Trial primary completion date, Surgery: Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma (clinicaltrials.gov) - Jun 11, 2015 P2, N=100, Terminated, Suspended --> Terminated; efficacy interim analysis as per protocol Active, not recruiting --> Terminated | Trial primary completion date: Dec 2012 --> Dec 2006
|